cbdinsomniastudy com


### Breaking New Ground in Insomnia Treatment: A Glimpse into Evrima Technologies' Innovative CBD Study

In the quest to conquer the elusive beast of insomnia, Evrima Technologies is at the forefront, pioneering research into alternative treatments that promise more than just a fleeting night's sleep. Their latest endeavor, a comprehensive study exploring the potential of CBD as a treatment for insomnia, has sparked considerable interest and hope among those plagued by sleepless nights.

#### Understanding the Plight of Insomnia

Insomnia, a common sleep disorder affecting a significant portion of the population, manifests as difficulty falling asleep, staying asleep, or waking up too early. The consequences of this disorder extend beyond mere tiredness, impacting mental health, productivity, and overall quality of life. In Australia alone, chronic insomnia is clinically diagnosed in 12% of the population, with up to 60% exhibiting at least one symptom of the condition. This alarming prevalence underscores the urgent need for effective, accessible treatments.

#### The Evrima Technologies Approach

Evrima Technologies, distinguished by its innovative approach to medical research, has identified the shortcomings of existing insomnia treatments, particularly their limited efficacy and the risk of next-day impairment. In response, the company has developed a promising new treatment, CBD TPM (the study drug), aiming to provide sufferers with natural, restorative sleep without the drawbacks of conventional medications.

#### Study Participation: Who Can Join?

This groundbreaking study is open to individuals who are:
- 18 years of age or older
- Experiencing difficulty with sleep for at least the past 3 months or diagnosed with insomnia
- Having a consistent sleep schedule
- Residing in NSW, QLD, VIC, or WA

Unfortunately, those consuming large amounts of caffeine, suffering from other sleep disorders, frequently napping, or currently using insomnia treatments are ineligible.

#### What to Expect from the Study

The study spans approximately 16 weeks, divided into a screening period, treatment phase, and follow-up. Participants will engage in both clinic visits and phone consultations, maintaining a daily diary and completing questionnaires to monitor their progress. Importantly, the study does not require overnight stays, respecting participants' time and routines.

#### The Potential Impact

Beyond personal health benefits, including free study-related medical care, participants will contribute to research that could pave the way for a new insomnia treatment paradigm. Reimbursement for out-of-pocket expenses is also provided, acknowledging the valuable role of participants in this pioneering research.

#### Getting Involved

For those tired of battling insomnia and interested in exploring new treatment avenues, this study represents a beacon of hope. Participation not only offers potential personal benefits but also contributes to broader medical research efforts aimed at improving sleep health for many.

Evrima Technologies, with its commitment to innovation and patient care, encourages eligible individuals to learn more and consider registering for the study. The journey toward better sleep and wellness may just begin with this promising research into the therapeutic potentials of CBD.

For additional information and to register, visit [cbdinsomniastudy.com] or [https://www.evrima.com/active-trials/cbd-insomnia-study], a gateway to understanding and potentially overcoming insomnia through cutting-edge research and compassionate care.



No comments: